View Full Version : Lymphoma Forum

  1. Getting the Facts on Lymphoma vaccines - Lymphoma Research Foundation
  2. Familial (inherited) leukemia, lymphoma, and myeloma: an overview.
  3. FDA Approves VELCADE(R) (Bortezomib) for Injection for Aggressive Form of Non-Hodgkin
  4. Results Reported at the American Society of Hematology Annual Meeting Affirm Impressi
  5. FDA Okays Zolinza for Cutaneous T-cell Lymphoma Skin Lesions
  6. Phase III Trial of Galiximab for Follicular Non-Hodgkin's Lymphoma In Combination wit
  7. UCLA Researchers Discover Genes Linked to Lymphoma, Opening Way for New Targeted Drug
  8. Lombardi expert helps set new guidelines for assessing lymphoma treatment
  9. Seattle Genetics Granted Orphan Drug Designation for AML and Hodgkin’s Disease Drug
  10. Researchers Funded by The Leukemia & Lymphoma Society Studying Agent to Target Gene L
  11. What You Need To Know About Non-Hodgkin's Lymphoma
  12. Risk of lymphoma increases with hepatitis C virus infection
  13. New Lymphoma treatment fights SYK causing cell death
  14. Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymph
  15. Yale study offers insight into possible cause of lymphoma
  16. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin's Lym
  17. Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Associatio
  18. Researchers Determine Risk Factors for Rare, Deadly form of Lymphoma
  19. Study makes exciting progress in elucidating the mechanisms of bortezomib in lymphoma
  20. Cell death assays for lymphatic neoplasms
  21. New lymphoma therapy may be more effective with fewer side effects
  22. Tumor Lysis Syndrome
  23. Penn Vet Researchers Show Lymphoma Drug Shrinks Dog Tumors, Could Lead to Human Treat
  24. Wnt Signaling Inhibitors
  25. Low grade B-Cell Non-Hodgkins Lymphoma
  26. Exercise is good medicine for lymphoma patients
  27. Rituxan (rituximab) Maintenance Therapy
  28. Tyrosine Kinase Inhibitor in Mantle Cell Lymphoma
  29. Breast Cancer After Hodgkin's Lymphoma
  30. Vivia Biotech and Ferrer to develop new drug for Non-Hodgkins Lymphoma
  31. Myc-Driven Cancer Susceptible To Afinitor (everolimus)
  32. Treatment-Related AML in Non-Hodgkin's Lymphoma
  33. Will Adcetris increase cure rate of advanced Hodgkin lymphoma?
  34. Immune system kills spontaneous blood cancer cells every day
  35. Surviving Stage IV Mantle Zone Lymphoma